A detailed history of Greater Midwest Financial Group, LLC transactions in Regeneron Pharmaceuticals, Inc. stock. As of the latest transaction made, Greater Midwest Financial Group, LLC holds 2,520 shares of REGN stock, worth $1.8 Million. This represents 1.55% of its overall portfolio holdings.

Number of Shares
2,520
Previous 2,502 0.72%
Holding current value
$1.8 Million
Previous $2.89 Billion 8.48%
% of portfolio
1.55%
Previous 1.83%

Shares

4 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2024

Oct 16, 2024

BUY
$1024.09 - $1201.76 $18,433 - $21,631
18 Added 0.72%
2,520 $2.65 Billion
Q2 2024

Sep 23, 2024

BUY
$883.2 - $1071.19 $179,289 - $217,451
203 Added 8.83%
2,502 $2.89 Billion
Q1 2024

Sep 23, 2024

BUY
$902.69 - $993.35 $28,886 - $31,787
32 Added 1.41%
2,299 $2.21 Billion
Q4 2023

Sep 23, 2024

BUY
$775.18 - $881.7 $1.76 Million - $2 Million
2,267 New
2,267 $1.99 Billion

Others Institutions Holding REGN

About REGENERON PHARMACEUTICALS, INC.


  • Ticker REGN
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 107,190,000
  • Market Cap $76.4B
  • Description
  • Regeneron Pharmaceuticals, Inc. discovers, invents, develops, manufactures, and commercializes medicines for treating various diseases worldwide. The company's products include EYLEA injection to treat wet age-related macular degeneration and diabetic macular edema; myopic choroidal neovascularization; and diabetic retinopathy, as well as macula...
More about REGN
Track This Portfolio

Track Greater Midwest Financial Group, LLC Portfolio

Follow Greater Midwest Financial Group, LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Greater Midwest Financial Group, LLC, based on Form 13F filings with the SEC.

News

Stay updated on Greater Midwest Financial Group, LLC with notifications on news.